These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH. Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548 [Abstract] [Full Text] [Related]
12. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. Nasirinezhad F, Jergova S, Pearson JP, Sagen J. Neuropharmacology; 2015 Aug; 95():100-9. PubMed ID: 25486617 [Abstract] [Full Text] [Related]
13. The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents. Sakin YS, Dogrul A, Ilkaya F, Seyrek M, Ulas UH, Gulsen M, Bagci S. Neurogastroenterol Motil; 2015 Jul; 27(7):936-44. PubMed ID: 25869205 [Abstract] [Full Text] [Related]
14. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. Spradley JM, Guindon J, Hohmann AG. Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378 [Abstract] [Full Text] [Related]
15. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. Seillier A, Dominguez Aguilar D, Giuffrida A. Pharmacol Biochem Behav; 2014 Sep; 124():153-9. PubMed ID: 24911644 [Abstract] [Full Text] [Related]